This report aims to provide a comprehensive presentation of the global market for Pharmaceuticals and Biotechnology R & D, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceuticals and Biotechnology R & D. This report contains market size and forecasts of Pharmaceuticals and Biotechnology R & D in global, including the following market information:
Global Pharmaceuticals and Biotechnology R & D Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pharmaceuticals and Biotechnology R & D market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Drug Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pharmaceuticals and Biotechnology R & D include ROCHE, JOHNSON & JOHNSON, MERCK, NOVARTIS, PFIZER, SANOFI, BAYER, BRISTOL-MYERS SQUIBB and ASTRAZENECA, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pharmaceuticals and Biotechnology R & D companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pharmaceuticals and Biotechnology R & D Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceuticals and Biotechnology R & D Market Segment Percentages, by Type, 2022 (%)
Drug
Medical Equipment
Vaccine
Others
Global Pharmaceuticals and Biotechnology R & D Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pharmaceuticals and Biotechnology R & D Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Homecare
Others
Global Pharmaceuticals and Biotechnology R & D Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pharmaceuticals and Biotechnology R & D Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pharmaceuticals and Biotechnology R & D revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pharmaceuticals and Biotechnology R & D revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
ROCHE
JOHNSON & JOHNSON
MERCK
NOVARTIS
PFIZER
SANOFI
BAYER
BRISTOL-MYERS SQUIBB
ASTRAZENECA
GLAXOSMITHKLINE
ABBVIE
ELI LILLY
BOEHRINGER SOHN
AMGEN
GILEAD SCIENCES
TAKEDA PHARMACEUTICAL
NOVO NORDISK
BIOGEN
ABBOTT
ASTELLAS PHARMA
TEVA PHARMACEUTICAL INDUSTRIES
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pharmaceuticals and Biotechnology R & D, market overview.
Chapter 2: Global Pharmaceuticals and Biotechnology R & D market size in revenue.
Chapter 3: Detailed analysis of Pharmaceuticals and Biotechnology R & D company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pharmaceuticals and Biotechnology R & D in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pharmaceuticals and Biotechnology R & D Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pharmaceuticals and Biotechnology R & D Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pharmaceuticals and Biotechnology R & D Overall Market Size
2.1 Global Pharmaceuticals and Biotechnology R & D Market Size: 2022 VS 2029
2.2 Global Pharmaceuticals and Biotechnology R & D Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pharmaceuticals and Biotechnology R & D Players in Global Market
3.2 Top Global Pharmaceuticals and Biotechnology R & D Companies Ranked by Revenue
3.3 Global Pharmaceuticals and Biotechnology R & D Revenue by Companies
3.4 Top 3 and Top 5 Pharmaceuticals and Biotechnology R & D Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pharmaceuticals and Biotechnology R & D Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R & D Players in Global Market
3.6.1 List of Global Tier 1 Pharmaceuticals and Biotechnology R & D Companies
3.6.2 List of Global Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R & D Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pharmaceuticals and Biotechnology R & D Market Size Markets, 2022 & 2029
4.1.2 Drug
4.1.3 Medical Equipment
4.1.4 Vaccine
4.1.5 Others
4.2 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue & Forecasts
4.2.1 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2023
4.2.2 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue, 2024-2029
4.2.3 By Type - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pharmaceuticals and Biotechnology R & D Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Homecare
5.1.5 Others
5.2 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue & Forecasts
5.2.1 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2023
5.2.2 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue, 2024-2029
5.2.3 By Application - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pharmaceuticals and Biotechnology R & D Market Size, 2022 & 2029
6.2 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue & Forecasts
6.2.1 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2023
6.2.2 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue, 2024-2029
6.2.3 By Region - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.3.2 US Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.3.3 Canada Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.3.4 Mexico Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.4.2 Germany Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.3 France Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.4 U.K. Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.5 Italy Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.6 Russia Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.7 Nordic Countries Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.4.8 Benelux Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.5.2 China Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.3 Japan Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.4 South Korea Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.5 Southeast Asia Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.5.6 India Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.6.2 Brazil Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.6.3 Argentina Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029
6.7.2 Turkey Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7.3 Israel Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7.4 Saudi Arabia Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
6.7.5 UAE Pharmaceuticals and Biotechnology R & D Market Size, 2018-2029
7 Pharmaceuticals and Biotechnology R & D Companies Profiles
7.1 ROCHE
7.1.1 ROCHE Company Summary
7.1.2 ROCHE Business Overview
7.1.3 ROCHE Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.1.4 ROCHE Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.1.5 ROCHE Key News & Latest Developments
7.2 JOHNSON & JOHNSON
7.2.1 JOHNSON & JOHNSON Company Summary
7.2.2 JOHNSON & JOHNSON Business Overview
7.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.2.4 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.2.5 JOHNSON & JOHNSON Key News & Latest Developments
7.3 MERCK
7.3.1 MERCK Company Summary
7.3.2 MERCK Business Overview
7.3.3 MERCK Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.3.4 MERCK Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.3.5 MERCK Key News & Latest Developments
7.4 NOVARTIS
7.4.1 NOVARTIS Company Summary
7.4.2 NOVARTIS Business Overview
7.4.3 NOVARTIS Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.4.4 NOVARTIS Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.4.5 NOVARTIS Key News & Latest Developments
7.5 PFIZER
7.5.1 PFIZER Company Summary
7.5.2 PFIZER Business Overview
7.5.3 PFIZER Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.5.4 PFIZER Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.5.5 PFIZER Key News & Latest Developments
7.6 SANOFI
7.6.1 SANOFI Company Summary
7.6.2 SANOFI Business Overview
7.6.3 SANOFI Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.6.4 SANOFI Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.6.5 SANOFI Key News & Latest Developments
7.7 BAYER
7.7.1 BAYER Company Summary
7.7.2 BAYER Business Overview
7.7.3 BAYER Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.7.4 BAYER Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.7.5 BAYER Key News & Latest Developments
7.8 BRISTOL-MYERS SQUIBB
7.8.1 BRISTOL-MYERS SQUIBB Company Summary
7.8.2 BRISTOL-MYERS SQUIBB Business Overview
7.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.8.4 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.8.5 BRISTOL-MYERS SQUIBB Key News & Latest Developments
7.9 ASTRAZENECA
7.9.1 ASTRAZENECA Company Summary
7.9.2 ASTRAZENECA Business Overview
7.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.9.4 ASTRAZENECA Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.9.5 ASTRAZENECA Key News & Latest Developments
7.10 GLAXOSMITHKLINE
7.10.1 GLAXOSMITHKLINE Company Summary
7.10.2 GLAXOSMITHKLINE Business Overview
7.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.10.4 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.10.5 GLAXOSMITHKLINE Key News & Latest Developments
7.11 ABBVIE
7.11.1 ABBVIE Company Summary
7.11.2 ABBVIE Business Overview
7.11.3 ABBVIE Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.11.4 ABBVIE Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.11.5 ABBVIE Key News & Latest Developments
7.12 ELI LILLY
7.12.1 ELI LILLY Company Summary
7.12.2 ELI LILLY Business Overview
7.12.3 ELI LILLY Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.12.4 ELI LILLY Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.12.5 ELI LILLY Key News & Latest Developments
7.13 BOEHRINGER SOHN
7.13.1 BOEHRINGER SOHN Company Summary
7.13.2 BOEHRINGER SOHN Business Overview
7.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.13.4 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.13.5 BOEHRINGER SOHN Key News & Latest Developments
7.14 AMGEN
7.14.1 AMGEN Company Summary
7.14.2 AMGEN Business Overview
7.14.3 AMGEN Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.14.4 AMGEN Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.14.5 AMGEN Key News & Latest Developments
7.15 GILEAD SCIENCES
7.15.1 GILEAD SCIENCES Company Summary
7.15.2 GILEAD SCIENCES Business Overview
7.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.15.4 GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.15.5 GILEAD SCIENCES Key News & Latest Developments
7.16 TAKEDA PHARMACEUTICAL
7.16.1 TAKEDA PHARMACEUTICAL Company Summary
7.16.2 TAKEDA PHARMACEUTICAL Business Overview
7.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.16.4 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.16.5 TAKEDA PHARMACEUTICAL Key News & Latest Developments
7.17 NOVO NORDISK
7.17.1 NOVO NORDISK Company Summary
7.17.2 NOVO NORDISK Business Overview
7.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.17.4 NOVO NORDISK Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.17.5 NOVO NORDISK Key News & Latest Developments
7.18 BIOGEN
7.18.1 BIOGEN Company Summary
7.18.2 BIOGEN Business Overview
7.18.3 BIOGEN Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.18.4 BIOGEN Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.18.5 BIOGEN Key News & Latest Developments
7.19 ABBOTT
7.19.1 ABBOTT Company Summary
7.19.2 ABBOTT Business Overview
7.19.3 ABBOTT Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.19.4 ABBOTT Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.19.5 ABBOTT Key News & Latest Developments
7.20 ASTELLAS PHARMA
7.20.1 ASTELLAS PHARMA Company Summary
7.20.2 ASTELLAS PHARMA Business Overview
7.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.20.4 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.20.5 ASTELLAS PHARMA Key News & Latest Developments
7.21 TEVA PHARMACEUTICAL INDUSTRIES
7.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Summary
7.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview
7.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Major Product Offerings
7.21.4 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Revenue in Global Market (2018-2023)
7.21.5 TEVA PHARMACEUTICAL INDUSTRIES Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pharmaceuticals and Biotechnology R & D Market Opportunities & Trends in Global Market
Table 2. Pharmaceuticals and Biotechnology R & D Market Drivers in Global Market
Table 3. Pharmaceuticals and Biotechnology R & D Market Restraints in Global Market
Table 4. Key Players of Pharmaceuticals and Biotechnology R & D in Global Market
Table 5. Top Pharmaceuticals and Biotechnology R & D Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pharmaceuticals and Biotechnology R & D Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pharmaceuticals and Biotechnology R & D Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pharmaceuticals and Biotechnology R & D Product Type
Table 9. List of Global Tier 1 Pharmaceuticals and Biotechnology R & D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pharmaceuticals and Biotechnology R & D Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pharmaceuticals and Biotechnology R & D Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2024-2029
Table 30. ROCHE Company Summary
Table 31. ROCHE Pharmaceuticals and Biotechnology R & D Product Offerings
Table 32. ROCHE Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 33. ROCHE Key News & Latest Developments
Table 34. JOHNSON & JOHNSON Company Summary
Table 35. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Product Offerings
Table 36. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 37. JOHNSON & JOHNSON Key News & Latest Developments
Table 38. MERCK Company Summary
Table 39. MERCK Pharmaceuticals and Biotechnology R & D Product Offerings
Table 40. MERCK Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 41. MERCK Key News & Latest Developments
Table 42. NOVARTIS Company Summary
Table 43. NOVARTIS Pharmaceuticals and Biotechnology R & D Product Offerings
Table 44. NOVARTIS Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 45. NOVARTIS Key News & Latest Developments
Table 46. PFIZER Company Summary
Table 47. PFIZER Pharmaceuticals and Biotechnology R & D Product Offerings
Table 48. PFIZER Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 49. PFIZER Key News & Latest Developments
Table 50. SANOFI Company Summary
Table 51. SANOFI Pharmaceuticals and Biotechnology R & D Product Offerings
Table 52. SANOFI Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 53. SANOFI Key News & Latest Developments
Table 54. BAYER Company Summary
Table 55. BAYER Pharmaceuticals and Biotechnology R & D Product Offerings
Table 56. BAYER Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 57. BAYER Key News & Latest Developments
Table 58. BRISTOL-MYERS SQUIBB Company Summary
Table 59. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Product Offerings
Table 60. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 61. BRISTOL-MYERS SQUIBB Key News & Latest Developments
Table 62. ASTRAZENECA Company Summary
Table 63. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Product Offerings
Table 64. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 65. ASTRAZENECA Key News & Latest Developments
Table 66. GLAXOSMITHKLINE Company Summary
Table 67. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Product Offerings
Table 68. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 69. GLAXOSMITHKLINE Key News & Latest Developments
Table 70. ABBVIE Company Summary
Table 71. ABBVIE Pharmaceuticals and Biotechnology R & D Product Offerings
Table 72. ABBVIE Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 73. ABBVIE Key News & Latest Developments
Table 74. ELI LILLY Company Summary
Table 75. ELI LILLY Pharmaceuticals and Biotechnology R & D Product Offerings
Table 76. ELI LILLY Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 77. ELI LILLY Key News & Latest Developments
Table 78. BOEHRINGER SOHN Company Summary
Table 79. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Product Offerings
Table 80. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 81. BOEHRINGER SOHN Key News & Latest Developments
Table 82. AMGEN Company Summary
Table 83. AMGEN Pharmaceuticals and Biotechnology R & D Product Offerings
Table 84. AMGEN Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 85. AMGEN Key News & Latest Developments
Table 86. GILEAD SCIENCES Company Summary
Table 87. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Product Offerings
Table 88. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 89. GILEAD SCIENCES Key News & Latest Developments
Table 90. TAKEDA PHARMACEUTICAL Company Summary
Table 91. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Product Offerings
Table 92. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 93. TAKEDA PHARMACEUTICAL Key News & Latest Developments
Table 94. NOVO NORDISK Company Summary
Table 95. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Product Offerings
Table 96. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 97. NOVO NORDISK Key News & Latest Developments
Table 98. BIOGEN Company Summary
Table 99. BIOGEN Pharmaceuticals and Biotechnology R & D Product Offerings
Table 100. BIOGEN Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 101. BIOGEN Key News & Latest Developments
Table 102. ABBOTT Company Summary
Table 103. ABBOTT Pharmaceuticals and Biotechnology R & D Product Offerings
Table 104. ABBOTT Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 105. ABBOTT Key News & Latest Developments
Table 106. ASTELLAS PHARMA Company Summary
Table 107. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Product Offerings
Table 108. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 109. ASTELLAS PHARMA Key News & Latest Developments
Table 110. TEVA PHARMACEUTICAL INDUSTRIES Company Summary
Table 111. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Product Offerings
Table 112. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Revenue (US$, Mn) & (2018-2023)
Table 113. TEVA PHARMACEUTICAL INDUSTRIES Key News & Latest Developments
List of Figures
Figure 1. Pharmaceuticals and Biotechnology R & D Segment by Type in 2022
Figure 2. Pharmaceuticals and Biotechnology R & D Segment by Application in 2022
Figure 3. Global Pharmaceuticals and Biotechnology R & D Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pharmaceuticals and Biotechnology R & D Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pharmaceuticals and Biotechnology R & D Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pharmaceuticals and Biotechnology R & D Revenue in 2022
Figure 8. By Type - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 16. US Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 20. Germany Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 21. France Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 28. China Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 32. India Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 34. Brazil Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pharmaceuticals and Biotechnology R & D Revenue Market Share, 2018-2029
Figure 37. Turkey Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pharmaceuticals and Biotechnology R & D Revenue, (US$, Mn), 2018-2029
Figure 41. ROCHE Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. MERCK Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. NOVARTIS Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. PFIZER Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. SANOFI Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. BAYER Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. ASTRAZENECA Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. ABBVIE Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. ELI LILLY Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. AMGEN Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. GILEAD SCIENCES Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. NOVO NORDISK Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. BIOGEN Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. ABBOTT Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R & D Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
